Professional Media briefs: May 2014

Share this article:
Ivan Oransky
Ivan Oransky

BMJ and the Lupus Foundation of America have published the first articles for Lupus Science & Medicine, which the partners said is the first lupus-specific open-access journal. Lupus Foundation CEO and President Sandra Raymond said in a statement that the foundation's publishing efforts have been scattered across non-lupus publications and that this journal “provides a much needed, centralized home for… lupus research findings.”

MedPage Today's Ivan Oransky's Retraction Watch has launched a subscriber service. Oransky (pictured) and partner Adam Marcus announced the service in a March post, alerting readers that subscriptions to the four-year-old blog would go toward such things as paying writers and creating a database. Funds will be handled by a third party, so as to protect the site's independence.

John Wiley & Sons has updated its 2006 Best Practice Guidelines on Publishing Ethics: A Publisher's Perspective. The goal remains to be a touchstone for advice on what the company calls “the major ethical principles of academic publishing.” The new edition includes guidance about whistle-blowers, clinical trial registration and other subjects.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters